Last Close
Feb 03  •  03:08PM ET
33.81
Dollar change
+0.19
Percentage change
0.56
%
CategoryEquity - Leveraged / Inverse Asset TypeEquities (Stocks) TagsU.S. Return% 1Y- Total Holdings11 Perf Week-1.90%
SponsorDirexion Shares ETF Type Tagsequity Return% 3Y- AUM4.20M Perf Month9.40%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter18.74%
IndexNYSE Biotechnology Top 5 Equal Weight In... Average Maturity Tagsbiotechnology Return% 10Y 52W High38.48 -12.12% Perf Half Y-
Index Weighting Commodity Type Tagsleverage Return% SI 52W Low25.44 32.92% Perf YTD8.84%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.65% 1.69% Perf Year-
Dividend TTM0.10 (0.30%) ESG Type Tags- Flows% 3M0.49% ATR (14)0.72 Perf 3Y-
Dividend Ex-DateDec 23, 2025 Dividend Type Sector/Theme Flows% YTD0.00% RSI (14)61.75 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.95% Growth/Value SMA206.18% Flows% 3Y Rel Volume0.07 Prev Close33.62
Inverse/Leveraged Market Cap SMA506.97% Flows% 5Y Avg Volume3.87K Price33.81
IPOOct 01, 2025 Option/ShortNo / Yes SMA20012.10% Trades Volume272 Change0.56%
Direxion Daily Biotech Top 5 Bull 2X ETF seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. The components of the index and the percentages represented by various sectors in the index may change over time. The fund is non-diversified.